Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 11 of 119 for:    ZIRCONIUM

Evaluation of Antagonist Wear Behavior and Patient Satisfaction of Zirconia Reinforced Lithium Silicate Glass When Compared to Monolithic Zirconia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03697018
Recruitment Status : Not yet recruiting
First Posted : October 5, 2018
Last Update Posted : October 8, 2018
Sponsor:
Information provided by (Responsible Party):
Esraa Mohamed Hany, Cairo University

Brief Summary:
evaluation of wear behavior and patient satisfaction of monolithic zirconia and zirconia reinforced glass crowns after follow-up periods 0,3,6,12 months.

Condition or disease Intervention/treatment Phase
Wear of the Natural Enamel Other: zirconia reinforced lithium silicate glass ceramic Not Applicable

Detailed Description:
two groups of patients will be selected according to special inclusion criteria n=13 in each group total of 26. each group will receive one of the crowns used in this study either ( monolithic zirconia or zirconia reinforced lithium silicate glass) after crown delivery wear and patient satisfaction will be recorded at 0,3,6,12 moths follow-up periods.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 26 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Masking Description: double blind
Primary Purpose: Treatment
Official Title: Evaluation of Antagonist Wear Behavior and Patient Satisfaction of Monolithic Zirconia Versus Lithium Silicate Zirconia Crowns
Estimated Study Start Date : October 2018
Estimated Primary Completion Date : October 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Eye Wear

Arm Intervention/treatment
Experimental: zirconia reinforced lithium silicate glass ceramic
It represent a new generation of glass ceramic material, enriched with zirconia (10% by weight), the material offers natural esthetics with successful outcome.
Other: zirconia reinforced lithium silicate glass ceramic
It represent a new generation of glass ceramic material. Using an innovative manufacturing process the glass ceramic is enriched with zirconia (10% by weight) for dental CAD/CAM applications for the fabrication of inlays, onlays, crowns and anterior and posterior single tooth restorations on implant abutments.

Active Comparator: monolithic zirconia
Zirconia or zirconium dioxide (ZrO2) is a highly attractive ceramic material in prosthodontics due to its excellent mechanical properties. It is widely used to build prosthetic devices.
Other: zirconia reinforced lithium silicate glass ceramic
It represent a new generation of glass ceramic material. Using an innovative manufacturing process the glass ceramic is enriched with zirconia (10% by weight) for dental CAD/CAM applications for the fabrication of inlays, onlays, crowns and anterior and posterior single tooth restorations on implant abutments.




Primary Outcome Measures :
  1. wear of the antagonist natural enamel [ Time Frame: from baseline till one year ]
    loss of opposing tooth structure which will be measured by 3D Profilometer


Secondary Outcome Measures :
  1. patient satisfaction [ Time Frame: from baseline till one year ]
    visual analogue scale (VAS): scale range from 0-10 for describing the intensity of pain the patient suffering. 0: no pain, 5: moderate pain, 10: unbearable pain.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Patient age range from 20-60 to be able to read and write in order to sign the informed consent document.
  2. Patients physically and psychologically able to tolerate conventional restorative procedures.
  3. Patients with no active periodontal and or pulpal diseases, having teeth with good restorations.
  4. Patients with root canal treated teeth requiring full coverage restorations.
  5. Patients indicated for full coverage (e.g. moderate to severe discoloration, coronal fracture, malposed or malformed teeth).
  6. Patients willing to return for follow-up examinations and assessments

Exclusion Criteria:

  1. Patients in the growth stage with partially erupted teeth.
  2. Patient with poor oral hygiene.
  3. Patients with psychiatric problems or unrealistic expectations
  4. Patient with no opposite occluding dentition in the area intended for restoration.
  5. Patient suffering from Para functional habits.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03697018


Contacts
Layout table for location contacts
Contact: esraa mohamed hany 00201005669044 esraamhany@gmail.com
Contact: hesham katamesh, professor 00201222102001

Sponsors and Collaborators
Cairo University

Layout table for additonal information
Responsible Party: Esraa Mohamed Hany, PHD candidate, fixed prosthodontic department, faculty of Oral and dental Medicine, Cairo University
ClinicalTrials.gov Identifier: NCT03697018     History of Changes
Other Study ID Numbers: CEBD-CU-2018-10-01
First Posted: October 5, 2018    Key Record Dates
Last Update Posted: October 8, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: conditions and factors which increase degree and progression of wear and clinical behavior of monolithic zirconia and zirconia reinforced lithium silicate restorations.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Lithium Carbonate
Methamphetamine
Central Nervous System Stimulants
Physiological Effects of Drugs
Sympathomimetics
Autonomic Agents
Peripheral Nervous System Agents
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Adrenergic Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Dopamine Uptake Inhibitors
Antidepressive Agents
Psychotropic Drugs
Enzyme Inhibitors
Antimanic Agents
Tranquilizing Agents
Central Nervous System Depressants